Selective and Sensitive UHPLC Method for the Trace Analysis of Formaldehyde in Drug Substance Using Fused-core Column Technology and Detailed Pre-column Derivatization study

Author:

Panchakarla Ravi Kiran1,Ravi Punna Rao2,Chandra Sekhar Kondapalli Venkata Gowri1

Affiliation:

1. Department of Chemistry, BITS-Pilani Hyderabad Campus, Jawaharnagar, Hyderabad, Medchal (Dist), Telangana 500078, India

2. Department of Pharmacy, BITS-Pilani Hyderabad Campus, Jawaharnagar, Hyderabad, Medchal (Dist), Telangana 500078, India

Abstract

Background: Formaldehyde is a key intermediate/reagent in the synthesis of many significant pharmaceutical compounds. It is genotoxic as it interacts with the DNA, RNA and hence there is a pressing need to develop sensitive analytical methods for its trace level determination. Objective: The present study aims to develop a simple and robust Ultra-High-Performance Liquid Chromatographic (UHPLC) method for the trace level quantification of a carcinogen-formaldehyde, in pharmaceutical drug substance. Methods: This method was developed on a conventional pre-column derivatization technique with brady’s reagent followed by fast analysis on fused core C18 Ascentis Express (150 × 4.6 mm, 2.7 μm) column using ultraviolet (UV) detection. Optimization of the derivatization reaction time was conducted in different pH conditions. The optimized analytical method was fully validated in accordance with the current International Conference on Harmonization (ICH) Q2 guidelines, which demonstrated the developed method to be fast, specific, linear, sensitive, repeatable, accurate and convenient for routine quality control. Results: The developed method was linear, accurate and precise in the concentration of 12.8 ng/mL to 510.7 ng/mL. The LOD and LOQ were found to be 3.8 ng/mL and 12.8 ng/mL, respectively. Conclusion: The developed UHPLC can be used effectively for trace level quantification of formaldehyde in drug substances or drug products.

Funder

DST-FIST

Publisher

Bentham Science Publishers Ltd.

Subject

Pharmaceutical Science,Molecular Medicine,Biochemistry,Biophysics

Reference54 articles.

1. ICT Harmonisation for better health. http://www.ich.org/fileadmin/public_web_site/ICH_products/guide lines/multidisciplinary/M7/M7_R1_addendum_step_4_2017_331.pdf

2. Evaluation of medicine for human use Accessed on: 28 June, Europian Medicines Agency2006 http://www.ema.europa.eu/docs/en_GB/document_library/Scientific_ guideline/2009/09/WC500002903.pdf

3. Authenticated US government information GPO https://www.gpo.gov/fdsys/pkg/FR-2008-12-16/pdf/E8-29674.pdf

4. Dobo K.L.; Greene N.; Cyr M.O.; Caron S.; Ku W.W.; The application of structure-based assessment to support safety and chemistry diligence to manage genotoxic impurities in active pharmaceutical ingredients during drug development. Regul Toxicol Pharmacol 2006,44(3),282-293

5. Question and Answer bon the CHMP in: Guideline on the Limits of Genotoxic Impurities, 2008

Cited by 1 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3